Exploring the theranostic potentials of miRNA and epigenetic networks in autoimmune diseases: A comprehensive review

  • Sagnik Nag
    Department of Bio‐Sciences School of Bio‐Sciences & Technology, Vellore Institute of Technology Vellore Tamil Nadu India
  • Oishi Mitra
    Department of Bio‐Sciences School of Bio‐Sciences & Technology, Vellore Institute of Technology Vellore Tamil Nadu India
  • Garima Tripathi
    Department of Bio‐Sciences School of Bio‐Sciences & Technology, Vellore Institute of Technology Vellore Tamil Nadu India
  • Souvik Samanta
    Department of Bio‐Sciences School of Bio‐Sciences & Technology, Vellore Institute of Technology Vellore Tamil Nadu India
  • Bikramjit Bhattacharya
    Integrative Multiomics Lab School of Bio‐Sciences & Technology, Vellore Institute of Technology Vellore Tamil Nadu India
  • Priti Chandane
    Department of Biochemistry School of Life Sciences University of Hyderabad Hyderabad Telangana India
  • Sourav Mohanto
    Department of Pharmaceutics Yenepoya Pharmacy College & Research Centre Yenepoya (Deemed to be University) Mangaluru Karnataka India
  • Vino Sundararajan
    Integrative Multiomics Lab School of Bio‐Sciences & Technology, Vellore Institute of Technology Vellore Tamil Nadu India
  • Sumira Malik
    Amity Institute of Biotechnology Amity University Jharkhand Ranchi Jharkhand India
  • Sarvesh Rustagi
    School of Applied and Life Sciences Uttaranchal University Dehradun Uttarakhand India
  • Suraj Adhikari
    Manipal College of Medical Sciences Pokhara Nepal
  • Aroop Mohanty
    Department of Clinical Microbiology All India Institute of Medical Sciences Gorakhpur Uttar Pradesh India
  • Darwin A. León‐Figueroa
    Facultad de Medicina Humana Universidad de San Martín de Porres Chiclayo Peru
  • Alfonso J. Rodriguez‐Morales
    Clinical Epidemiology and Biostatistics, School of Medicine Universidad Científica del Sur Lima Peru
  • Joshuan J. Barboza
    Escuela de Medicina Universidad César Vallejo Trujillo Peru
  • Ranjit Sah
    Department of Clinical Microbiology Institute of Medicine, Tribhuvan University Teaching Hospital Kathmandu Nepal

抄録

<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Autoimmune diseases (AD) are severe pathophysiological ailments that are stimulated by an exaggerated immunogenic response towards self‐antigens, which can cause systemic or site‐specific organ damage. An array of complex genetic and epigenetic facets majorly contributes to the progression of AD, thus providing significant insight into the regulatory mechanism of microRNA (miRNA). miRNAs are short, non‐coding RNAs that have been identified as essential contributors to the post‐transcriptional regulation of host genome expression and as crucial regulators of a myriad of biological processes such as immune homeostasis, T helper cell differentiation, central and peripheral tolerance, and immune cell development.</jats:p></jats:sec><jats:sec><jats:title>Aims</jats:title><jats:p>This article tends to deliberate and conceptualize the brief pathogenesis and pertinent epigenetic regulatory mechanism as well as miRNA networks majorly affecting five different ADs namely rheumatoid arthritis (RA), type 1 diabetes, multiple sclerosis (MS), systemic lupus erythematosus (SLE) and inflammatory bowel disorder (IBD) thereby providing novel miRNA‐based theranostic interventions.</jats:p></jats:sec><jats:sec><jats:title>Results & Discussion</jats:title><jats:p>Pertaining to the differential expression of miRNA attributed in target tissues and cellular bodies of innate and adaptive immunity, a paradigm of scientific expeditions suggests an optimistic correlation between immunogenic dysfunction and miRNA alterations.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Therefore, it is not astonishing that dysregulations in miRNA expression patterns are now recognized in a wide spectrum of disorders, establishing themselves as potential biomarkers and therapeutic targets. Owing to its theranostic potencies, miRNA targets have been widely utilized in the development of biosensors and other therapeutic molecules originating from the same.</jats:p></jats:sec>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ